References
- Salliot C, van der Heijde D. Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis 2009;68:1100–14.
- Diouf ML, Diallo S, Mbengue M, Moreira-Diop T. Methotrexate, liver and rheumatoid arthritis in tropical areas. Sante 2001;11: 195–200.
- Kremer JM, Alarcon GS, Lightfoot RW Jr, Willkens RF, Furst DE, Williams HJ, . Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. Arthritis Rheum 1994;37: 316–28.
- Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J, . Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis 2009;68:1086–93.
- Kelly WN, Arellano F, Barnes J, Bergman U, Edwards IR, Fernandez AM, . Guidelines for submitting adverse event reports for publication. Pharmacoepidemiol Drug Saf 2007;16: 581–7.
- Electronic Medicines Compendium (eMC). 10 September 2010. Summary of product characteristics: Humira, Enbrel, Remicade. Available from: http://emc.medicines.org.uk (accessed 5 January 2011).
- Sasajima T, Suzuki T, Mori K, Ichii O, Tai M, Ochiai H, . A case of idiopathic portal hypertension associated with rheumatoid arthritis. Mod Rheumatol 2006;16:92–6.
- Giner Galvan V, Oltra MR, Rueda D, Esteban MJ, Redon J. Severe acute hepatitis related to hydroxychloroquine in a woman with mixed connective tissue disease. Clin Rheumatol 2007; 26:971–2.
- Carmichael SJ, Beal J, Day RO, Tett SE. Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate. J Rheumatol 2002;29:2077–83.
- Endresen GK, Husby G. Folate supplementation during methotrexate treatment of patients with rheumatoid arthritis. An update and proposals for guidelines. Scand J Rheumatol 2001;30:129–34.